Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4198 USD | +4.30% | -8.72% | -19.59% |
Business Summary
Number of employees: 35
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cancer Novel Drugs
100.0
%
| 0 | nan % | 12 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| - | - | 12 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Carl Firth
FOU | Founder | 51 | 09-12-31 |
Kiran Asarpota
DFI | Director of Finance/CFO | 45 | 10-10-31 |
Chief Tech/Sci/R&D Officer | - | 22-03-14 | |
Stephen Doyle
PRN | Corporate Officer/Principal | 50 | 18-01-31 |
Ben Goodger
LAW | General Counsel | 61 | 16-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hoffman
BRD | Director/Board Member | 58 | 18-10-29 |
Andrew Howden
CHM | Chairman | 64 | 16-03-31 |
Carl Firth
FOU | Founder | 51 | 09-12-31 |
Kathleen Metters
BRD | Director/Board Member | 66 | 21-03-17 |
Neil Graham
BRD | Director/Board Member | 65 | 21-02-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 337,297,360 | 333,924,386 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Aslan Pharmaceuticals Ltd.
3 Temasek Avenue 18 Level Centennial Tower
039190, Singapore
+
http://www.aslanpharma.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.59% | 9.11M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- ASLN Stock
- Company ASLAN Pharmaceuticals Limited